esi run on the cards?

ISN has never looked better.

Beaten down ex management and a stale market has provided a great opening for a few reasons.

ISN is embarking on a very interesting phase as it transfers its IP into software as opposed to the traditional wheezometer. With smart phones a massive and growing market ISN will have the most comprehensive asthma app available. A trickle of interest in this and the $$ will be rolling in.


Secondly ISN has 15 patents and growing. They are very well guarded all that they need is a push from a major.

Thirdly they have great management team in place that I am backing to get this lifted off.

Finally the current price is ridiculous. Compounding factors have contributed to its current state but soon the market will catch on and rerate her. Esi went bunta over a few months. ISN will take time but there is some serious value to be realised here imo.

Judging by the press around lately it looks like many agree also.. All the best